This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit May 21, 2014


 

Advertisement

Low-dose CT lung cancer screening recommendations will up diagnoses
HealthDay News via HCP Live
Implementation of the US Preventive Services Task Force recommendations for low-dose computed tomography (LDCT) lung cancer screening is expected to increase lung cancer diagnosis and increase Medicare expenditure. These findings have been released in advance of presentation at the annual meeting of the American Society of Clinical Oncology, to be held from May 30 to June 3 in Chicago, Ill.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


74 cancer care facilities receive national achievement award
Commission on Cancer
The Commission on Cancer (CoC) of the American College of Surgeons has granted its Outstanding Achievement Award (OAA) to a select group of 74 accredited cancer programs across the United States.

Established in 2004, the CoC OAA recognizes cancer programs that strive for excellence in providing quality care to cancer patients. The award is granted to facilities that demonstrate a Commendation level of compliance with seven standards that represent four areas of program management, clinical services, patient outcomes, and data quality. The level of compliance with the seven standards is determined during an on-site evaluation by a physician surveyor. In addition, facilities must receive a compliance rating for each of the remaining 27 cancer program standards. Seventy-four programs received the OAA as a result of surveys performed in 2013. This number represents approximately 14 percent of cancer programs surveyed during this period. A majority of recipients are community-based facilities; however, academic hospitals, integrated networks, a pediatric facility, and a freestanding cancer center also received this year's award.

The CoC press release announcing the 2013 OAA recipients is now online. OAA programs are also listed online.


Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Low testosterone may indicate worsening of low-risk prostate cancer
Oncology Nurse Advisor
For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease, concluded a new study. The findings may help physicians identify patients with low-risk prostate cancer who should receive aggressive anticancer treatment. Men with prostate cancer that is not life threatening and is only slowly progressing can often forego treatment and instead undergo active surveillance.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Coming soon — Learning the Basics of CoC Accreditation Workshop
Commission on Cancer
The first program, held early this year, was a sell-out. To meet the numerous requests, the Commission on Cancer (CoC) will repeat Learning the Basics of CoC Accreditation on September 12, 2014, in San Antonio, Texas. Plan now to attend the only program developed by the professionals who are involved in CoC standards development and the survey process. Watch your e-mail for detailed information or contact srubin@facs.org.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Could breastfeeding, birth control pills reduce risk of ovarian cancer?
Medical News Today
Mutations in the BRCA1 and BRCA2 genes are known to increase the risk of female breast and ovarian cancers. But a new study published in the Journal of the National Cancer Institute finds that breastfeeding, taking oral contraceptives, and tubal ligation may reduce ovarian cancer risk for women with these mutations. The BRCA1 and BRCA2 genes are responsible for producing tumor suppressor proteins in the body. These proteins help repair damaged DNA and, in turn, make sure a cell's genetic material is stable.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Radioimmunotherapy plus chemotherapy shows promise for metastatic pancreatic ductal cancer
HemOnc Today
Small doses of an investigational radioimmunotherapy combined with small doses of the chemotherapy drug gemcitabine were shown to provide "superior outcomes" over radioimmunotherapy alone, according to recent research presented at an American Association for Cancer Research conference, Pancreatic Cancer: Innovations in Research and Treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


National Cancer Survivors Day
Commission on Cancer
June 1 marks the 27th Annual National Cancer Survivors Day that brings cancer survivors together to show that there is life after receiving a diagnosis of cancer. The Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC) encourage your center to observe this day and use it as an opportunity to display/promote your CoC and/or NAPBC accreditation status. To help you promote this event within your program and the community, the CoC and the NAPBC have developed a poster that you can download and print. To access the poster, CoC-accredited programs can go to CoC Datalinks and click on the “Marketing Resources”; NAPBC-accredited centers can log into the NAPBC Portal and click “Marketing Page” under the Marketing Resources tab. For information, please contact Susan Rubin.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Tailored intervention does not up colorectal cancer screening rates
HealthDay News via HCP Live
An interactive multimedia computer program (IMCP) tailored to expanded health belief model sociopsychological factors is no more effective for encouraging colorectal cancer screening than a control nontailored informational program, according to a study published in the May/June issue of the Annals of Family Medicine. Anthony Jerant, MD, from the University of California Davis School of Medicine in Sacramento, and colleagues conducted a randomized trial to examine whether an IMCP could promote colorectal cancer screening in a multiethnic sample.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FORDS revision project
Commission on Cancer, National Cancer Data Base
FORDS is a manual that contains all of the data items with rules and coding options for cancer registrars to collect data in their hospital registry. These data are then submitted to the National Cancer Data Base (NCDB). The data available in the NCDB come from FORDS, Collaborative Stage, and the AJCC Cancer Staging Manual. The Commission on Cancer (CoC) is seeking input from registrars, data users, physicians, and others to modernize the current FORDS manual. This project kicked off in April 2014. The input will be gathered through an electronic survey, which will be open through September 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Gene expression profiling weighs heavily in decisions for breast cancer patients yet poorly understood
Oncology Nurse Advisor
Gene expression profiling tests play a critical role when women with early-stage breast cancer decide whether to receive chemotherapy. However, many of the patients do not fully understand what some of the test results mean, new research has suggested. Current guidelines for treating early-stage breast cancer, with no metastasis to nearby lymph nodes or other parts of the body, result in thousands of women receiving chemotherapy without benefitting from it.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Senator Brown expands on unfair cancer screening costs
Digital Journal
U.S. Sen. Sherrod Brown (D-Ohio) has held a news conference call to announce legislation to ensure seniors who need colon cancer preventive procedures are not hit with unfair and burdensome costs. The issue is that under current law, seniors covered by Medicare are eligible for free colorectal cancer screenings. However, if a doctor needs to take a further lifesaving, preventive action — like removing a polyp — while the patient is under anesthesia, the patient is billed as if the procedure was treatment rather than prevention.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 
Advertisement

Advertisement



The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Samantha Emerson, Content Editor, 469.420.2669
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

May 14, 2014
May 7, 2014
April 30, 2014
April 23, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063